JBP1 catalyzes the hydroxylation of thymine in DNA to form hydroxymethyluracil (hmU), a precursor to base J. This modification is essential for regulating transcription termination and chromatin structure in kinetoplastid parasites . Key properties include:
Dioxygenase Activity: Requires Fe²⁺ and 2-oxoglutarate (2-OG) for enzymatic function .
DNA Binding Specificity: Recognizes J-containing DNA (J-DNA) with 10,000-fold preference over unmodified DNA via a helical bouquet fold domain (DB-JBP1) .
Role in Pathogenesis: Essential in Leishmania for maintaining genomic J levels but dispensable in T. brucei, where its absence reduces J levels by ~95% .
The DB-JBP1 domain (residues 460–620) mediates J-DNA binding through:
JBP1 functions as a thymidine hydroxylase (TH), converting thymine to hmU in duplex DNA . This activity is abolished by mutations in Fe²⁺/2-OG-binding residues (e.g., His487, Arg510) .
While no JBP1-specific antibody is described in the provided sources, related methodologies include:
Anti-J Antibodies: Used to immunoprecipitate J-DNA in chromatin studies .
Recombinant JBP1: Purified for in vitro assays (e.g., fluorescence anisotropy, hydroxylation activity) .
Disruption of JBP1-J-DNA interaction is a potential target for antiparasitic drugs. For example:
Mutating Asp525 or inhibiting Fe²⁺/2-OG cofactors blocks J biosynthesis .
T. brucei JBP1/2 double knockouts lack base J entirely, enabling functional studies of J-deficient parasites .
KEGG: lif:LINJ_09_1560
STRING: 435258.XP_001463611.1
JBP1 is a protein that binds to DNA base J in trypanosomatids. Research has established that JBP1 functions as a thymidine hydroxylase, responsible for converting thymine specifically in double-stranded DNA to hydroxymethyluracil (hmU) in an Fe²⁺/2-oxoglutarate-dependent manner . This enzymatic activity makes JBP1 crucial for understanding unique DNA modification processes in trypanosomatid parasites. The significance of JBP1 extends beyond its enzymatic function, as it works alongside JBP2 in a two-step process for J-biosynthesis, with JBP1 playing a key role in amplifying basal levels of J initially established by JBP2 .
JBP1 antibodies are essential tools for multiple research applications including:
Detection and quantification of JBP1 protein through Western blotting
Immunolocalization studies to determine subcellular distribution
Chromatin immunoprecipitation (ChIP) to study JBP1-DNA interactions
Co-immunoprecipitation to identify JBP1 protein interaction partners
Flow cytometry analysis of JBP1 in cell populations
These applications enable researchers to investigate the functional roles of JBP1 in base J synthesis and the biological consequences of this DNA modification across different experimental contexts .
For maintaining antibody integrity and performance, JBP1 antibodies should typically be stored at -20°C for routine use, with long-term storage recommended at -80°C . Avoid repeated freeze-thaw cycles, which can compromise antibody activity. Most commercial antibodies are supplied in phosphate-buffered saline (PBS) at pH 7.5 with sodium azide (0.05%) as a preservative . When handling antibodies, use appropriate personal protective equipment and maintain sterile conditions to prevent contamination.
When conducting experiments with JBP1 antibodies, several controls are essential:
Positive control: Lysates or samples from wild-type cells known to express JBP1
Negative control: Samples from JBP1 knockout or null cells (JBP1⁻/⁻)
Isotype control: Non-specific antibody of the same isotype and host species
Peptide competition assay: Pre-incubation of antibody with excess JBP1 peptide/protein
Secondary antibody-only control: To assess non-specific binding
These controls are particularly important given the specificity requirements for distinguishing JBP1 from other proteins, including the related JBP2 .
For effective Western blotting with JBP1 antibodies:
Sample preparation: Lyse cells in an appropriate buffer (e.g., RIPA) containing protease inhibitors
Protein quantification: Use BCA or Bradford assay to ensure equal loading
SDS-PAGE: Typically use 8-10% gels for JBP1 (molecular weight considerations)
Transfer: PVDF membranes are recommended for optimal protein binding
Blocking: 5% non-fat milk or BSA in TBST (1-2 hours at room temperature)
Primary antibody incubation: Dilute JBP1 antibody 1:500 to 1:2000 in blocking buffer, incubate overnight at 4°C
Washing: 3-5 washes with TBST, 5-10 minutes each
Secondary antibody: HRP-conjugated anti-rabbit IgG (if using rabbit polyclonal JBP1 antibody)
Detection: Enhanced chemiluminescence (ECL) system
The specific dilution and incubation conditions may need optimization based on the particular antibody used and sample characteristics .
For immunoprecipitation (IP) with JBP1 antibodies:
Cell lysis: Use gentle lysis buffers (e.g., 50 mM HEPES, 100 mM NaCl, 0.5% NP-40) with protease inhibitors
Pre-clearing: Incubate lysate with protein A/G beads to remove non-specific binding proteins
Antibody binding: Add 2-5 μg of JBP1 antibody per 500 μg of protein lysate, incubate overnight at 4°C with gentle rotation
Immunoprecipitation: Add fresh protein A/G beads, incubate 2-4 hours at 4°C
Washing: Wash beads 4-5 times with lysis buffer
Elution: Use SDS sample buffer or gentle elution buffer depending on downstream applications
Analysis: Western blot, mass spectrometry, or other techniques
For co-IP experiments, use lower stringency wash buffers to preserve protein-protein interactions .
Investigating JBP1-JBP2 functional relationships requires sophisticated approaches:
Sequential ChIP (ChIP-reChIP): Using antibodies against both JBP1 and JBP2 to identify regions where both proteins co-localize
Co-immunoprecipitation: JBP1 antibodies can be used to pull down JBP1 and associated proteins, followed by Western blotting for JBP2
Proximity ligation assay (PLA): To visualize and quantify JBP1-JBP2 protein interactions in situ
Comparative ChIP-seq: Analyze genome-wide binding patterns of JBP1 versus JBP2
Knockout/complementation studies: Use JBP1/JBP2 double knockout cells with selective re-expression of either protein
Research has shown that JBP1 and JBP2 have distinct but complementary roles in J biosynthesis; JBP2 initiates site-specific J synthesis, while JBP1 amplifies J levels at these specific sites .
To ensure JBP1 antibody specificity:
Western blot analysis: Compare wild-type versus JBP1 knockout samples
Competition assays: Pre-incubate antibody with purified recombinant JBP1 protein
Multiple antibody validation: Use different antibodies targeting distinct JBP1 epitopes
siRNA/knockout validation: Check for signal reduction after JBP1 knockdown/knockout
Mass spectrometry: Confirm identity of immunoprecipitated proteins
Cross-reactivity testing: Test against related proteins (especially JBP2)
Validation is particularly important given the structural and functional similarities between JBP1 and JBP2, as both are thymidine hydroxylases involved in J biosynthesis .
While JBP1 antibodies target the protein itself, detecting the product of JBP1 activity (hmU) requires different approaches:
In vitro TH (thymidine hydroxylase) assay: Incubate recombinant JBP1 with duplex DNA in the presence of Fe²⁺, 2-oxoglutarate, and ascorbic acid, then detect hmU formation using:
Experimental considerations:
These methods have revealed that JBP1-mediated hydroxylation is highly specific for double-stranded DNA contexts, correlating with the specificity of the J-DNA binding domain at the C-terminus of JBP1 .
JBP1 antibodies enable several approaches to study the J biosynthesis pathway:
Chromatin immunoprecipitation (ChIP): Identify genomic regions where JBP1 binds and initiates J formation
Immunofluorescence microscopy: Visualize JBP1 localization during different cell cycle stages or life cycle phases
Protein complex analysis: Identify proteins that interact with JBP1 during J biosynthesis
In vitro reconstitution: Using purified components including JBP1 to reconstruct the J biosynthesis pathway
Research using these approaches has revealed that JBP1 operates optimally in internal regions involved in RNA polymerase II transcription, while JBP2 functions preferentially within telomeric-localized repetitive DNA . This functional difference appears to be due to distinct C-terminal domains on each enzyme .
Several techniques can detect JBP1-J-DNA interactions:
DNA binding assays: Using purified recombinant JBP1 and J-containing oligonucleotides
Electrophoretic mobility shift assay (EMSA): Visualize complex formation between JBP1 and J-DNA
Surface plasmon resonance (SPR): Measure binding kinetics and affinity
ChIP followed by qPCR or sequencing: Map JBP1 binding to genomic regions containing J
Mutation analysis: Testing JBP1 mutants for J-DNA binding capacity
Studies have shown that inactivation of the N-terminal thymidine hydroxylase domain has no effect on J-DNA binding, indicating that JBP1 binding to J-DNA is independent from its thymidine hydroxylase activity .
To investigate JBP1 function across life cycles:
Life-stage specific expression analysis: Using JBP1 antibodies for Western blot or immunofluorescence
Conditional knockout systems: Inducible depletion of JBP1 at specific life stages
Complementation experiments: Reintroducing wild-type or mutant JBP1 into JBP1-null backgrounds
Differential ChIP analysis: Compare JBP1 binding patterns across life stages
Transcriptomic and proteomic profiling: Assess global changes upon JBP1 deletion
Research has shown significant differences in JBP1 function between different trypanosomatid life stages. For instance, in the trypanosome insect stage that normally lacks base J, JBP2 stimulates site-specific de novo base J synthesis, while JBP1 expression leads to additional J synthesis in these specific regions .
For accurate quantification of JBP1:
Western blot quantification:
Use housekeeping proteins (tubulin, GAPDH) as loading controls
Employ digital image analysis software for densitometry
Generate standard curves using recombinant JBP1 if absolute quantification is needed
qRT-PCR for transcript analysis:
Flow cytometry:
Use isotype controls and unstained controls
Report median fluorescence intensity (MFI)
Include positive and negative control populations
Data presentation: Results should be presented as mean ± standard deviation, with appropriate statistical analysis (Student's t-test, with p<0.05 considered significant) .
To assess JBP1 activity modulation:
In vivo inhibition assays:
Genomic J quantification:
hmU detection:
These approaches have been successfully used to demonstrate that inhibitors of Fe²⁺/2-oxoglutarate-dependent dioxygenases can reduce J synthesis, confirming the enzymatic nature of JBP1 .